Please use this identifier to cite or link to this item: 10.3390/M1438
Title: 1,1′-{[3,5-Bis((dodecyloxycarbonyl)-4-phenyl-1,4-dihydropyridine-2,6-diyl]bis(methylene)}bis[4-(anthracen-9-yl)pyridin-1-ium] Dibromide
Authors: Ozolins, Reinis
Plotniece, Mara
Pajuste, Karlis
Putralis, Reinis
Pikun, Nadiia
Sobolev, Arkadij
Plotniece, Aiva
Rucins, Martins
Department of Pharmaceutical Chemistry
Keywords: 1,4-dihydropyridine;anthracene;DLS;fluorescent dyes;nanoparticles;pyridinium;self-assembling properties;synthetic lipids;1.4 Chemical sciences;3.1 Basic medicine;1.1. Scientific article indexed in Web of Science and/or Scopus database;Biochemistry;Physical and Theoretical Chemistry;Organic Chemistry
Issue Date: Sep-2022
Citation: Ozolins , R , Plotniece , M , Pajuste , K , Putralis , R , Pikun , N , Sobolev , A , Plotniece , A & Rucins , M 2022 , ' 1,1′-{[3,5-Bis((dodecyloxycarbonyl)-4-phenyl-1,4-dihydropyridine-2,6-diyl]bis(methylene)}bis[4-(anthracen-9-yl)pyridin-1-ium] Dibromide ' , MolBank , vol. 2022 , no. 3 , M1438 . https://doi.org/10.3390/M1438
Abstract: A synthesis of a cationic moiety and fluorescent moieties containing amphiphilic 1,4-dihydropyridine (1,4-DHP) derivatives was performed starting with the Hantzsch-type cyclization of dodecyl acetoacetate, phenylaldehyde and ammonium acetate. Bromination of the 2,6-dimethyl groups of a parent 1,4-DHP compound, followed by nucleophilic substitution of bromine with 4-(anthracen-9-yl)pyridine, produced the desired 1,1′-{[3,5-bis((dodecyloxycarbonyl)-4-phenyl-1,4-dihydropyridine-2,6-diyl]bis(methylene)}bis[4-(anthracen-9-yl)pyridin-1-ium] dibromide. The obtained target compound was fully characterized by the IR, 1H NMR, 13C NMR and HRMS data. Studies of the self-assembling properties and characterization of the nanoparticles obtained by the ethanol injection method were performed using dynamic light scattering (DLS) measurements. DLS measurement data showed that 1,1′-{[3,5-bis((dodecyloxycarbonyl)-4-phenyl-1,4-dihydropyridine-2,6-diyl]bis(methylene)}bis[4-(anthracen-9-yl)pyridin-1-ium] dibromide produced liposomes that had average diameters of 200 nm when the samples were freshly prepared, and 140 nm after 7 days or 1 month storage. The PDI values of the samples were approximately 0.50 and their zeta-potential values were approximately 41 mV when the samples were freshly prepared, and 33 mV after storage. The obtained nanoparticles were stored at room temperature for one month and remained stable during that period. The mean molecular area of the cationic 1,4-DHP-anthracene hybrid 4 was 118 Å2, while the mean molecular area of the cationic 1,4-DHP 5 without anthracene substituents was only 83 Å2. The photoluminescence quantum yield (PLQY) value for the EtOH solution of the 1,4-DHP derivative 4 was 10.8%, but for the 1,4-DHP derivative 5 it was only 1.8%. These types of compounds could be used as synthetic lipids in the further development of prospective theranostic delivery systems.
Description: Funding Information: This research was funded by the EuroNanoMed3 Project NANO4GLIO No ES RTD/2020/9, the PostDocLatvia Project No 1.1.1.2/VIAA/2/18/373 (N.P.) and the PostDocLatvia Project No 1.1.1.2/VIAA/3/19/587 (K.P.). Publisher Copyright: © 2022 by the authors.
DOI: 10.3390/M1438
ISSN: 1422-8599
Appears in Collections:Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure

Files in This Item:
File SizeFormat 
molbank_2022_M1438.pdf612.49 kBAdobe PDFView/Openopen_acces_unlocked


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.